Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
A recently published report entitled Global Lemongrass Essential Oil Market 2020, by Manufacturers, Type and Application, Forecast to 2025 presents extensive assessments based on...